73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Dienstag, 31.05.2022
Experimentelle Neuroonkologie II/Experimental neurooncology II
Meeting Abstract
(V143)
[Volltext]
Prevalence of M2c macrophages in newly diagnosed glioblastoma correlates with an exhausted PD-1+/Tim-3+ effector memory T-cell phenotype with low IFNg-production
Kuballa M, Datsi A, Rapp M, Knobbe-Thomsen C, Sabel M, Sorg RV[Volltext]
Meeting Abstract
(V144)
[Volltext]
The effect of a novel Aurora-A kinase inhibitor in combination with tumour treating fields and temozolomide on glioblastoma cells
Novikova K, Michen S, Robel K, Temme A, Krex D[Volltext]
Meeting Abstract
(V145)
[Volltext]
Tumour Treating Fields (TTFields) promotes Rho kinase-dependent phosphorylation of the tight junction protein claudin-5
Salvador E, Keßler AF, Burek M, Tempel Brami C, Voloshin-Sela T, Volodin A, Adel Z, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C[Volltext]
Meeting Abstract
(V146)
[Volltext]
Electrical signaling is essential for dynamic transcriptional plasticity in Glioblastoma
Joseph K, Vollmer L, Ravi VM, Beck J, Hofmann U, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(V147)
[Volltext]
Combined treatment with ONC201/TIC10 and ABT-263 results in a synergistic anti-medulloblastoma activity in vitro
Spilz A, Dwucet A, Seyfried F, Peraud A, Prabhu VV, Allen JE, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G[Volltext]
Meeting Abstract
(V148)
[Volltext]
Evaluation of 3-L- and 3-D-[18F] Fluorophenylalanines as PET tracers for tumour imaging
Timmer M, Krämer F, Gröner B, Hoffmann C, Craig A, Brugger M, Drzezga A, Neumaier F, Zlatopolskiy B, Endepols H, Neumaier B[Volltext]
